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Abstract. 
 
Neurotrophins have been shown to acutely 
modulate synaptic transmission in a variety of systems, 
but the underlying signaling mechanisms remain un-
clear. Here we provide evidence for an unusual mecha-
nism that mediates synaptic potentiation at the neuro-
muscular junction (NMJ) induced by neurotrophin-3 
(NT3), using 
 
Xenopus
 
 nerve–muscle co-culture. Unlike 
brain-derived neurotrophic factor (BDNF), which re-
 
quires Ca
 
2
 
1
 
 inﬂux for its acute effect, NT3 rapidly en-
hances spontaneous transmitter release at the develop-
ing NMJ even when Ca
 
2
 
1
 
 inﬂux is completely blocked, 
suggesting that the NT3 effect is independent of extra-
cellular Ca
 
2
 
1
 
. Depletion of intracellular Ca
 
2
 
1
 
 stores, or 
blockade of inositol 1, 4, 5-trisphosphate (IP3) or ryan-
odine receptors, prevents the NT3-induced synaptic po-
tentiation. Blockade of IP3 receptors can not prevent 
BDNF-induced potentiation, suggesting that BDNF 
and NT3 use different mechanisms to potentiate trans-
mitter release. Inhibition of Ca
 
2
 
1
 
/calmodulin-depen-
dent kinase II (CaMKII) completely blocks the acute 
effect of NT3. Furthermore, the NT3-induced potentia-
 
tion requires a continuous activation of CaMKII, because 
application of the CaMKII inhibitor KN62 reverses the 
previously established NT3 effect. Thus, NT3 potenti-
ates neurotransmitter secretion by stimulating Ca
 
2
 
1
 
 re-
lease from intracellular stores through IP3 and/or ryan-
odine receptors, leading to an activation of CaMKII.
Key words: ryanodine receptors • inositol 1, 4,
5-trisphosphate receptors • acetylcholine • neuromus-
cular junction • synaptic transmission
 
Introduction
 
Nerve growth factor, brain-derived neurotrophic factor
(BDNF),
 
1
 
 neurotrophin-3 (NT3), and NT4 belong to the
neurotrophin family of signaling proteins essential for the
survival and differentiation of different populations of
neurons. Recent studies have revealed an important but
previously unrecognized role of neurotrophins in synapse
transmission and plasticity (for reviews see Lu and Fig-
urov, 1997; McAllister et al., 1999). In the central nervous
system (CNS), the synaptic actions of neurotrophins have
been studied mainly in the visual cortex and hippocampus.
For example, BDNF and NT4, which activate TrkB recep-
tor, but not NT3, which primarily activates TrkC receptor,
have long-term modulatory effects on the formation of oc-
ular dominance columns in the visual cortex (Cabelli et al.,
1995, 1997; Riddle et al., 1995). In layer 4 and 6 of the vi-
sual cortex, BDNF and NT3 oppose each other in regulat-
ing the dendritic growth of pyramidal neurons (McAllister
et al., 1995, 1997). In the hippocampus, BDNF has been
shown to acutely regulate synaptic plasticity such as long-
term potentiation (LTP) (Korte et al., 1995; Figurov et al.,
1996; Patterson et al., 1996). In contrast, several recent re-
ports have demonstrated that NT3 is not involved in the
modulation of hippocampal LTP (Figurov et al., 1996; Ko-
kaia et al., 1998; Ma et al., 1999). These studies suggest
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that the signaling mechanisms for BDNF and NT3 may be
quite different.
Due to the complexity of CNS synapses, the mecha-
nisms underlying the synaptic actions of neurotrophins are
difficult to study. The neuromuscular junction (NMJ) of-
fers a simple and easily accessible model to study the role
and the mechanisms of neurotrophins in synaptic devel-
opment and function in great detail. Two modes of
neurotrophic regulation have been identified using the
 
Xenopus
 
 nerve–muscle co-cultures: acute potentiation of
neurotransmitter release and long-term regulation of syn-
apse maturation. In the long-term mode, the spontaneous
synaptic currents (SSCs) and impulse–evoked synaptic
currents exhibit more mature properties after a prolonged
treatment with NT3, and to a lesser extent, with BDNF
(Wang et al., 1995; Liou and Fu, 1997; Liou et al., 1997).
The neurotrophins induce an increase in the expression of
synaptic vesicle proteins, and in the number of synaptic
varicosities in the presynaptic site (Wang et al., 1995), as
well as changes in the acetylcholine (ACh) receptors in the
postsynaptic site (Wang and Poo, 1997; Gonzalez et al.,
1999). In the acute mode, application of BDNF or NT3
rapidly enhances synaptic transmission at the NMJ (Lohof
et al., 1993). The acute effect of neurotrophins is due
strictly to an enhancement of transmitter release probabil-
ity in the presynaptic site (Lohof et al., 1993; Stoop and
Poo, 1995). The SSC frequency is markedly increased,
whereas the quantal sizes are not affected. The expression
of NT3, but not BDNF or NT4, in the postsynaptic muscle
cells is activity-dependent (Xie et al., 1997). Further, the
secretion of NT4 in muscle cells seems to be induced by re-
petitive stimulation of presynaptic neurons (Wang and
Poo, 1997). These results suggest that neurotrophins may
serve as target-derived, retrograde messengers that acutely
modulate transmitter release at the developing neuromus-
cular synapses (Xie et al., 1997).
A critical and yet unresolved question is: what are the
intracellular signaling mechanisms that mediate such rapid
synaptic effects of neurotrophins? In the hippocampus,
BDNF-induced enhancement of high frequency transmis-
sion at CA1 synapses appears to be mediated through the
activation of mitogen-associated protein kinase and phos-
phatidylinositol-3 kinase pathways, but not phospholipase
C-
 
g
 
 pathway (Gottschalk et al., 1999). The acute modula-
tion of synaptic transmission by BDNF at NMJ appears to
require Ca
 
2
 
1
 
 influx into the presynaptic terminals, but sig-
naling events downstream of Ca
 
2
 
1
 
 influx are not known
(Stoop and Poo, 1996). Do neurotrophins share similar
mechanisms in modulating synapses in the CNS and at the
NMJ? Do BDNF and NT3 use the same signaling pathway
to potentiate the neuromuscular synapses? In this report,
we address the role of the nerve terminal Ca
 
2
 
1
 
 in the acute
regulation of neurotransmitter release at the NMJ by NT3.
Specifically, we focus on the intracellular Ca
 
2
 
1
 
 stores
and the presynaptic Ca
 
2
 
1
 
/calmodulin-dependent kinase II
(CaMKII). A number of recent studies have suggested the
involvement of intracellular Ca
 
2
 
1
 
 stores in synaptic trans-
mission (for review see Berridge, 1998). Although exten-
sive studies have revealed diverse effects of CaMKII in
postsynaptic functions (Chapman et al., 1995), the only
clearly defined presynaptic effects of CaMKII is to regu-
late the availability of readily releasable synaptic vesicles
 
at the nerve terminals (Llinas et al., 1985; Greengard et al.,
1993). We have now provided evidence that the acute po-
tentiation of transmitter release by NT3 depends on a rise
of Ca
 
2
 
1
 
 concentrations ([Ca
 
2
 
1
 
]i) in the presynaptic termi-
nals. Surprisingly, the increase in [Ca
 
2
 
1
 
]i was due to Ca
 
2
 
1
 
released from intracellular stores, but not to Ca
 
2
 
1
 
 influx
from extracellular sources. Furthermore, the continuous
activation of CaMKII, which is triggered by the increase in
[Ca
 
2
 
1
 
]i, appears to be required for the effect of NT3.
These results may help understand how neurotrophins
acutely modulate neurotransmitter release.
 
Materials and Methods
 
Embryo Injection 
 
Specific peptide inhibitor for CaMKII (Ishida et al., 1995) (500 
 
m
 
M; Cal-
biochem) was mixed with rhodamine-dextran (10 
 
m
 
g/
 
m
 
l, mol wt 10,000) at
1:1 ratio. Approximately 6–12 nl of the solution was injected into one blas-
tomere of embryos at the 2- to 4-cell stage by a Picospritzer. The final con-
centration of the peptide within an injected blastomere was 
 
z
 
12.5 
 
m
 
M. 1 d
after injection, the neural tube and the associated myotomal tissues were
dissected and used to prepare nerve–muscle cultures. Cells containing
CaMKII-pep were identified by rhodamine fluorescence.
 
Culture Preparation
 
Xenopus
 
 nerve–muscle cultures were prepared according to the proce-
dure described previously (Lu et al., 1992). In brief, the neural tube and
the associated myotomal tissue of 
 
Xenopus
 
 embryos at stage 20 to 22 were
dissociated in Ca
 
2
 
1
 
-Mg
 
2
 
1
 
–free saline supplemented with EDTA (58.2 mM
NaCl, 0.7 mM KCl, 0.3 mM EDTA, pH 7.4) for 15–20 min. The cells were
grown on glass coverslips for 24 h at room temperature (20–22
 
8
 
C). The
culture medium consisted (vol/vol) of 50% Leibovitz L-15 medium
(Sigma), 1% FCS (Life Technologies), and 49% Ringer’s solution
(115 mM NaCl, 2 mM CaCl
 
2
 
, 2.5 mM KCl, 10 mM Hepes, pH 7.6). NT3
(2–5 
 
3
 
 10
 
2
 
9
 
 M; kindly provided by Regeneron Pharmaceuticals, Inc.) and
various inhibitors were applied directly to the culture media at the time of
recording.
 
Electrophysiology
 
Synaptic currents were recorded at room temperature in culture medium
from myocytes innervated by spinal motoneurons using whole cell, volt-
age-clamp recording techniques (Lu et al., 1992). The solution inside the
recording pipette contained: 150 mM KCl, 1 mM NaCl, 1 mM MgCl
 
2
 
, and
10 mM Hepes buffer, pH 7.2. Membrane currents in all recordings were
monitored by a patch clamp amplifier (EPC-7), with a current signal filter
at 3 kHz. The membrane potentials of the muscle cells were generally in
the range of 
 
2
 
55–
 
2
 
75 mV and were voltage clamped at 
 
2
 
70 mV after
measuring the membrane potentials. For experiments performed in the
absence of external Ca
 
2
 
1
 
, the culture medium was replaced with a Ca
 
2
 
1
 
-
free extracellular solution containing 115 mM NaCl, 2 mM MgCl
 
2
 
, 10 mM
Hepes, 3 mM EGTA, and 0.1% BSA. All data were stored on a videotape
recorder for later playback on a storage oscilloscope (Tektronix TDS 420)
and a chart recorder (Gould EasyGraf 240), or analysis using the SCAN
program. To quantitatively measure the changes in neurotransmitter re-
lease, a time course of SSC frequency was first constructed on a minute-
to-minute basis. The SSC frequencies in a 10-min period right before drug
application were averaged as control. The changes in SSC frequency were
measured by averaging a 10-min period recording starting from the high-
est number after drug application.
 
Results
 
Ca
 
2
 
1
 
 Influx Is Not Required for NT3-induced
Synaptic Potentiation
 
We recorded synaptic activities at the neuromuscular syn-
apses in 1-d-old 
 
Xenopus
 
 nerve–muscle cultures using whole 
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cell, voltage-clamp recording techniques. The SSCs are in-
duced by spontaneous secretion of individual ACh-con-
taining synaptic vesicles from motor nerve terminals inde-
pendent of action potentials, since they are not affected in
the presence of tetrodotoxin (Song et al., 1997). As shown
before (Lohof et al., 1993; Stoop and Poo, 1995, 1996),
acute application of NT3 (50 ng/ml) to the synapses in the
presence of extracellular Ca
 
2
 
1
 
 
 
dramatically enhanced spon-
taneous transmitter release, as reflected by a rapid increase
in the frequency of SSCs (Fig. 1 A). A previous report
showed that in the same type of cultures, BDNF enhances
synaptic transmission by facilitating Ca
 
2
 
1
 
 
 
influx into the
presynaptic terminals (Stoop and Poo, 1996). We thus
tested whether the acute NT3 effect uses a similar mecha-
nism. The culture medium was substituted with Ca
 
2
 
1
 
-free
extracellular solution after several washes with the same
solution. Surprisingly, application of NT3 still elicited an
increase in the frequency of SSCs under the zero external
Ca
 
2
 
1
 
 condition (Fig. 1 B and Fig. 2). The time courses of
the NT3-induced increase in SSC frequency in both Ca
 
2
 
1
 
-
free and Ca
 
2
 
1
 
-containing media were very similar, although
the basal level of SSC frequency in Ca
 
2
 
1
 
-free media before
NT3 application was slightly lower (Fig. 2, A and B).
Quantitative analysis indicated that NT3 only increased
the frequency, without affecting the amplitude or decay
time of SSCs (data not shown), suggesting that NT3 facili-
tates presynaptic transmitter release in the absence of ex-
tracellular Ca
 
2
 
1
 
. To further examine the role of membrane
Ca
 
2
 
1
 
 channels, we blocked Ca
 
2
 
1
 
 
 
influx by the general Ca
 
2
 
1
 
channel blocker Cd
 
2
 
1
 
 
 
(0.4 mM). NT3 was still capable of
elevating SSC frequency in the presence of Cd
 
2
 
1
 
 
 
(Fig. 2
B). Thus, NT3-induced potentiation of transmitter release
does not depend on Ca
 
2
 
1
 
 influx from extracellular sources.
Our further analyses were thus performed mostly in Ca
 
2
 
1
 
-
free medium.
 
Role of Intracellular Ca
 
2
 
1
 
 Stores
 
We next determined whether the NT3 effect is mediated
by an increase in Ca
 
2
 
1
 
 
 
release from intracellular Ca
 
2
 
1
 
stores. Thapsigargin inhibits Ca
 
2
 
1
 
-ATPase activity and
therefore has frequently been used to deplete all intracel-
lular Ca
 
2
 
1
 
 
 
stores (Thastrup et al., 1990). Application of
thapsigargin (2 
 
m
 
M) in both normal (
 
n
 
 5 
 
5, data not
shown) and Ca
 
2
 
1
 
-free media (Fig. 3 A) elicited a transient
increase in SSC frequency, which returned to control lev-
els within 20–60 min. NT3 no longer elicited any changes
in SSC frequency in thapsigargin-treated synapses (Fig. 3,
A and B). When intracellular Ca
 
2
 
1
 
 
 
stores were depleted by
thapsigargin, application of hypertonic solution (sucrose,
500 mM) to the synapses in Ca
 
2
 
1
 
-free medium still elicited
a transient but marked increase in transmitter release, sug-
gesting that there are still synaptic vesicles in the nerve
terminals (data not shown). Thus, the lack of NT3 effect in
thapsigargin-treated synapses was not due to vesicle de-
pletion. These results suggest that an increase in [Ca
 
2
 
1
 
]i
due to Ca
 
2
 
1
 
 
 
release from intracellular stores may con-
tribute to the facilitation of transmitter release by in-
duced NT3.
There are two major pathways for the release of Ca
 
2
 
1
 
from intracellular stores: the inositol 1, 4, 5-trisphosphate
(IP3) receptor and the ryanodine receptor (Berridge,
1998). Application of the IP3 receptor inhibitor xestospon-
gin C (XeC; 1 
 
m
 
M) (Gafni et al., 1997) prevented the in-
crease of SSC frequency elicited by NT3 (Fig. 3 B). The re-
lease of Ca
 
2
 
1
 
 from IP3 receptors could further trigger
Ca
 
2
 
1
 
-induced Ca
 
2
 
1
 
 release from ryanodine receptors (Ber-
ridge, 1998). Low concentration of ryanodine (2.5–5 
 
m
 
M)
may be used as a ryanodine receptor agonist, whereas high
concentration (100 
 
m
 
M) may serve as an antagonist. In
Ca
 
2
 
1
 
-free medium, application of ryanodine at high con-
centration (100 
 
m
 
M) had no effect on basal SSCs, but pre-
vented the increase in SSC frequency induced by NT3
(Fig. 3 B) (
 
P 
 
. 
 
0.5, ANOVA). Pretreatment of the cul-
tures with another ryanodine receptor antagonist 8-(deth-
ylamino)octyl 3, 4, 5-trimethoxybenzoate (TMB-8) (30
 
m
 
M) (Hunt et al., 1990) also blocked the NT3 effects (Fig.
3B). Unlike thapsigargin, however, ryanodine at lower
concentration (2.5–5 
 
m
 
M) was not sufficient to elicit a con-
sistent increase in SSC frequency (Fig. 3 C). Furthermore,
application of NT3 in the presence of low concentration of
ryanodine still elicited an increase in SSC frequency (Fig. 3
Figure 1. Acute potentiation
of transmitter release at NMJ
by NT3 is independent of ex-
tracellular Ca21. (A) A sam-
ple recording showing that
application of NT3 (50 ng/ml)
rapidly increases the fre-
quency of SSCs in the normal
culture medium. (B) Appli-
cation of NT3 also rapidly in-
creases the frequency of
SSCs in the Ca21-free me-
dium. 
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C). Thus, the synaptic action of NT3 is primarily mediated
by the Ca
 
2
 
1
 
 
 
release from IP3 receptors, which further trig-
gers Ca
 
2
 
1
 
 release from the ryanodine receptors.
We then tested whether BDNF, which requires Ca
 
2
 
1
 
 
 
in-
flux to enhance transmitter release (Stoop and Poo, 1996),
also depends on Ca
 
2
 
1
 
 release from intracellular stores.
Application of BDNF (50 ng/ml) elicited a fivefold in-
crease in SSC frequency in normal Ca
 
2
 
1
 
-containing me-
dium (Fig. 3 D). In cultures pretreated with XeC (1 
 
mM)
Figure 2. NT3-induced synaptic potentiation does not require
Ca21 influx. (A) Time courses of NT3 effect on spontaneous syn-
aptic activity in zero external Ca21 (open circles). The culture
medium was replaced by Ca21-free solution. The SSC frequency
was monitored before and after NT3 application. Each point rep-
resents averaged SSC frequency in 3 min of recording. An exam-
ple of recordings in normal medium (filled circles) is included for
comparison. (B) The effect of NT3 on SSC frequency in Ca21-
free medium (n 5 12) or in medium containing the Ca21 channel
blocker, Cd21 (CdCl2, 0.4 mM, n 5 13). For each synapse, a time
course of SSC frequency was first constructed on a minute-to-
minute basis. SSC frequencies are averaged from a 10-min re-
cording right before NT3 application for controls, and a 10-min
period starting from the highest number after NT3 application
for NT3-treated groups. Error bars in this and all other figures
are SEM. NT3 induced significant increases in SSC frequency in
both conditions (P , 0.005, t test). Similar methods were used to
calculate averaged SSC frequencies in all other figures, unless in-
dicated otherwise.
Figure 3. Enhancement of transmitter release by NT3, but not
BDNF, requires Ca21 release from intracellular Ca21 stores. All
experiments were carried out in Ca21-free conditions, except that
shown in D. The cultures were incubated with various drugs for
15–60 min, and SSCs were recorded continuously to monitor the
effects of the drug and NT3 application. Thapsigargin was used to
deplete Ca21 from intracellular stores. Asterisk indicates data
that are significantly different from the rest (P , 0.01, ANOVA
test followed by post hoc comparison). (A) An example showing
that thapsigargin (2 mM) prevents the NT3 effect. Application of
thapsigargin (open arrow) elicited a transient but marked in-
crease in SSC frequency due to the Ca21 release from intracellu-
lar stores. Application of NT3 after SSC frequency returned to
normal could no longer increase the SSC frequency. (B) Sum-
mary of the drug effects. Final concentration of the drugs in the
culture media: thapsigargin, 2 mM; XeC, 1 mM; TMB-8, 30 mM;
and ryanodine as an antagonist, 100 mM. The number of synapses
recorded are indicated in the control bar of each pair. Asterisk
indicates P , 0.005, t test. SSC frequencies are calculated in the
same way as Fig. 2. (C) Summary of the effects of ryanodine as an
agonist (2.5–5 mM). The SSC frequencies from a single synapse
are counted for a 10-min period in control and a 10-min period
after ryanodine application, and then a 10-min period after NT3
application. The data are then averaged and normalized to con-
trols (n 5 9). Note that ryanodine at the low concentration could
not block the NT3 effect. (D) BDNF-induced synaptic potentia-
tion is independent of Ca21  release from intracellular stores
through IP3 receptors. BDNF was applied to culture dishes in the
presence (right, n 5 5) or absence (left, n 5 5) of the IP3 receptor
inhibitor XeC (1 mM).He et al. Mechanisms of NT3-induced Synaptic Potentiation 787
to block IP3 receptors, BDNF elicited the same magnitude
of synaptic potentiation (Fig. 3 D), suggesting that the
Ca21 release from intracellular stores is not required for
BDNF-induced synaptic potentiation. Thus, BDNF and
NT3, two proteins from the same neurotrophin family, can
both potentiate neurotransmitter release, but they use to-
tally different intracellular mechanisms.
The Effect of NT3 Requires Continuous Activation
of CaMKII
The release of Ca21 from intracellular Ca21 stores induced
by NT3 may trigger the activation of the presynaptic
CaMKII. CaMKII has been shown to enhance transmitter
release in adult squid giant synapses and mammalian brain
synaptosomes, presumably due to an increase in the avail-
ability of readily releasable synaptic vesicles at the nerve
terminals (Llinas et al., 1985; Nichols et al., 1990). We first
tested whether CaMKII is involved in modulating trans-
mitter release at the developing NMJ in the Xenopus cul-
ture system using KN62, a frequently used inhibitor for
CaMKII (Tokumitsu et al., 1990). We found that bath ap-
plication of KN62 (3 mM) rapidly and reversibly reduced
the amplitude of evoked synaptic currents. The average
evoked synaptic current amplitudes before and 10 min af-
ter KN62 application were 1.77 1 0.36 nA and 1.01 1 0.24
nA, respectively (n 5 8, P , 0.01, t test). In contrast, appli-
cation of KN62 had little effect on the spontaneous release
of neurotransmitters (Fig. 4, A and B). These results are
consistent with the idea that CaMKII may regulate trans-
mitter release when the terminal [Ca21]i is elevated, but may
not be very effective at the quiescent level of [Ca21]i. Since
NT3 acts presynaptically at the NMJ and CaMKII is
capable of regulating transmitter release, we determined
whether CaMKII is involved in the synaptic action of NT3
at the developing NMJ. Pretreatment of the nerve–muscle
cultures with KN62 completely prevented the increase of
SSC frequency elicited by NT3 (Fig. 4). The average SSC
frequencies before and 10 min after KN62 remained un-
changed (before KN62; 5.9 6 0.6 events/min; after KN62,
5.6 6 0.6 events/min; n 5 8, P . 0.1). These results suggest
that CaMKII is necessary for the NT3 regulation of neu-
rotransmitter release.
KN62 may also inhibit other Ca21/calmodulin-depen-
dent protein kinases (Enslen et al., 1994). To ensure that
the NT3 effect is indeed mediated by CaMKII, we loaded
a specific peptide inhibitor (CaMKII-pep) (Ishida et al.,
1995) into the presynaptic neurons using embryo injection
techniques (Alder et al., 1992; Lu et al., 1992). CaMKII-
pep was injected together with rhodamine-dextran into
one of the blastomeres of Xenopus embryos at the two-cell
stage. The embryos were allowed to develop until stage 22
before being used to prepare the nerve–muscle co-cul-
tures. Introduction of the CaMKII-pep did not appear to
affect the development and morphology of the Xenopus
embryos at the time of cell culture (not shown). The spinal
neurons and the myocytes 1 d after cultures also exhibited
normal morphology (Fig. 5 A). It has been shown that the
rhodamine fluorescence faithfully reflects the cells con-
taining the coinjected exogenous proteins (Alder et al.,
1992; Lu et al., 1992). In cultures derived from injected
embryos, substantial numbers of neurons and myocytes
were CaMKII-pep–positive, as indicated by the rhoda-
mine fluorescence (Fig. 5 A, N1 and M1).
Fig. 5 B shows SSCs recorded from a pair of synapses in
which the presynaptic neurons were loaded with or with-
out CaMKII-pep into normal Ca21 medium, respectively.
At the CaMKII-pep (2) synapse, application of NT3 still
resulted in a marked increase in SSC frequency (Fig. 5, B
and C). In contrast, loading of CaMKII-pep into the pre-
synaptic neurons completely prevented the effects of NT3
(Fig. 5, B and C). Similar to KN62, loading of CaMKII-
pep to the presynaptic neurons did not affect basal sponta-
neous transmitter release, but blocked the effect of NT3
(Fig. 5 C). Similar results were obtained in Ca21-free me-
dium (Fig. 5 C). Furthermore, when CaMKII-pep was
loaded into the postsynaptic myocytes (M1), NT3 was still
capable of eliciting a significant increase in SSC frequency
(Fig. 5 C). Taken together, these results strongly suggest
that potentiation of transmitter release at the developing
neuromuscular synapses by NT3 is achieved through the
activation of CaMKII in the presynaptic neurons, but not
the postsynaptic muscle cells.
Does the NT3-induced potentiation require a continu-
ous activation of CaMKII? To address this question, we
applied KN62 after synaptic transmission was potentiated
by NT3. Fig. 6 A shows that within z20–30 min after NT3
application, the increase in SSC frequency reached the
peak. Application of KN62 at the peak gradually sup-
Figure 4. Effect of KN62 on NT3-induced synaptic potentiation.
(A) A sample recording showing that pretreatment of the neuro-
muscular synapse with KN62 prevents the NT3-induced facilita-
tion of transmitter release. (B) Blockade of NT3-induced synap-
tic potentiation of SSC frequency by KN62. In KN62 groups, the
nerve–muscle cultures were pretreated with KN62 for 10–20 min
before application of NT3. The number of synapses recorded are
indicated above each pair of columns. In each experiment, SSC
frequency was calculated from a 10-min recording period, and
then the number after NT3 treatment was normalized to that be-
fore NT3 application. Asterisk indicates P , 0.01, t test.The Journal of Cell Biology, Volume 149, 2000 788
pressed the SSC frequency. Quantitative analysis indi-
cated that KN62 virtually reversed the NT3 effect (Fig. 6
B). Thus, continuous activity of CaMKII appears to be
necessary for NT3 modulation of transmitter release at the
developing neuromuscular synapses.
Discussion
Previous work has shown that neurotrophins rapidly po-
tentiate synaptic transmission through presynaptic mecha-
nisms. The acute potentiation of transmitter release by
BDNF is accompanied by a rise in [Ca21]i in both the NMJ
(Stoop and Poo, 1995) and at the CNS synapses (Bern-
inger and Garcia, 1993; Marsh and Palfrey, 1996; Sakai et
al., 1997; Li et al., 1998). However, it is unclear whether
and how the increase in [Ca21]i mediates the neurotro-
phin-induced synaptic potentiation and which downstream
signaling events are involved. In this paper we report a
surprising finding that the acute potentiation of transmit-
ter release by NT3 at the neuromuscular synapses is inde-
pendent of Ca21 influx from extracellular sources. Instead,
this potentiation is mediated by Ca21 released from intra-
cellular stores through IP3 and ryanodine receptors. Thus,
the mechanisms by which BDNF and NT3 modulate trans-
mitter release could be quite different. Furthermore, we
demonstrated that Ca21 released from intracellular stores
is capable of activating CaMKII, and the continuous acti-
vation of CaMKII is required for the effect of NT3. Taken
together, this study provides, to our knowledge, the first
evidence for a link between neurotrophins and CaMKII.
These findings may provide new insights into the general
mechanisms of neurotransmitter release and exocytosis,
Figure 5. Inhibition of CaMKII prevents the effect of NT3. A peptide inhibitor for CaMKII (CaMKII-pep), together with rhodamine-
dextran, was injected into Xenopus embryo at the two-cell stage, and the nerve–muscle co-cultures were prepared from the injected em-
bryos. (A) Super-imposed phase and fluorescence micrographs of the 1-d-old nerve–muscle co-cultures showing cells loaded with (1)
or without (2) CaMKII-pep. N, spinal neurons; M, myocytes. (B) A pair of recordings showing that loading of CaMKII peptide into
presynaptic neurons N(1) prevented the NT3-induced increase in SSC frequency, whereas NT3 still enhanced transmitter release in a
N(2) neuron in the same culture. (C) Summary of the effect of CaMKII-pep loaded into either presynaptic spinal neurons or postsyn-
aptic myocytes. The number of synapses recorded are indicated above each pair of columns. In all N2 conditions, application of NT3
elicited a significant increase in SSC frequency (P , 0.01, t test).He et al. Mechanisms of NT3-induced Synaptic Potentiation 789
and how neurotrophic factors may regulate these pro-
cesses.
In addition to extracellular Ca21, the release of Ca21
from intracellular stores could either modulate or contrib-
ute directly to transmitter release (Berridge, 1998). Signals
that result in the opening of either IP3 receptors or ryano-
dine receptors can generate local increases in [Ca21]i,
which in turn participates in the exocytotic process. Al-
though still a fairly new concept, transmitter release trig-
gered or modulated by the release of Ca21 from intracellu-
lar stores has been shown in a number of systems such as
the cholinergic synapse in Aplysia, reticulospinal synapse
in lamprey, and sympathetic nerve terminals (Smith and
Cunnane, 1996; Cochilla and Alford, 1998; Mothet et al.,
1998). An important question then is whether neurotro-
phins, which are capable of eliciting an IP3 signal through
the activation of phospholipase-g pathway (Segal and
Greenberg, 1996), can serve as endogenous neuromodula-
tors to regulate synaptic transmission under physiological
conditions. In this study, we have provided strong evi-
dence that NT3 potentiates transmitter release by stimu-
lating Ca21  release from intracellular stores. We have
shown that NT3 increased transmitter release in Ca21-free
or Cd21-containing medium, and that pretreatment with
thapsigargin prevented the NT3 effect. Moreover, inhibi-
tion of IP3 receptors blocked the NT3 effect. Thus, NT3
induces the release of Ca21 through IP3 receptors at the
terminals of developing spinal neurons, leading to an in-
crease in spontaneous transmitter secretion. It is conceiv-
able that similar mechanisms are used for NT3 to enhance
evoked synaptic transmission, although we could not test
this possibility because most of our experiments have to be
done in Ca21-free medium. Consistent with our results,
neurotrophins have been shown to induce an increase in
[Ca21]i in hippocampal neurons (Berninger and Garcia,
1993; Marsh and Palfrey, 1996), possibly by enhancing the
release of Ca21 from intracellular stores (Sakai et al., 1997;
Li et al., 1998). The release of Ca21 from IP3 receptors
could further trigger Ca21-induced Ca21 release from ry-
anodine receptors (Berridge, 1998). We found that the
acute modulation of transmitter release by NT3 was
blocked by the ryanodine receptor antagonist TMB-8 or a
high concentration of ryanodine (100 mM). However, acti-
vation of the ryanodine receptor alone by low concentra-
tions of ryanodine (2.5–5 mM) was not sufficient to en-
hance transmitter release, and application of NT3 on top
of that still increased SSC frequency. Thus, both IP3 re-
ceptors and ryanodine receptors are involved in the acute
effect of NT3, but the primary effect of NT3 is probably on
the IP3 receptors. Although the electrophysiological anal-
ysis clearly indicates that NT3 potentiates neurotransmit-
ter release through presynaptic mechanisms, our pharma-
cological experiments can not formally establish that NT3
acts on presynaptic terminals directly. We can not rule out
the possibility that NT3 initially acts on postsynaptic mus-
cle cells to trigger the release of Ca21 from intracellular
stores, leading to the secretion of some retrograde signal
to activate presynaptic CaMKII.
Although our results suggest a role of Ca21 release from
internal stores in NT3-induced synaptic potentiation, a
previous study has shown that the acute potentiation by
BDNF in the same preparation requires external Ca21
(Stoop and Poo, 1996). BDNF binds and interacts almost
exclusively with the TrkB receptor, whereas NT3 binds
primarily to the TrkC receptor (Kaplan and Stephens,
1994). It is possible that the activation of TrkB triggers
Ca21 influx, whereas that of TrkC is coupled to internal
Ca21 stores in the developing spinal neurons. Indeed, we
found that inhibition of Ca21 release from internal stores
can not block the BDNF-induced synaptic potentiation.
Similarly, both BDNF and NT3 attract growth cone turn-
ing in these developing spinal neurons, but the intracellu-
lar mechanisms that mediate the turning responses to the
two factors are completely different (Song et al., 1998).
The BDNF effect requires Ca21 influx into the terminals
and elevation of [cAMP]i, whereas the NT3 effect is inde-
pendent of extracellular Ca21. In this study, we show that
the activation of IP3 receptors is required for the synaptic
effect of NT3, but not for that of BDNF. Thus, although
Figure 6. Reversal of NT3 effects by addition of KN62 after NT3
application. (A) Examples showing the time courses that KN62
reverses the NT3 effect. NT3 was first applied (filled arrow) to
the culture medium to elicit an increase in the frequency of SSCs.
After the SSC frequency reached the peak, KN62 (open arrow)
was either applied (open circles) or not applied (filled circles),
and synaptic currents were continuously monitored. (B) Sum-
mary of the reversal effect of KN62. SSC frequencies are calcu-
lated in the same way as Fig. 3 C. n 5 5. Asterisk indicates P ,
0.01, t test.The Journal of Cell Biology, Volume 149, 2000 790
both enhance synaptic transmission at developing neuro-
muscular synapses, the two factors may require Ca21 from
difference sources, one extracellular and one intracellular.
The potentiation of transmitter release usually occurs at
least 5–10 min after NT3 application (Figs. 1, 2, and 6; see
also Lohof et al., 1993; Xie et al., 1997). This time course
implies that NT3-induced Ca21 release modulates the
transmitter release mechanisms, rather than contributing
directly to the triggering of the exocytosis process. The
NT3 modulation is known to be presynaptic in nature (Lo-
hof et al., 1993). What are the presynaptic targets down-
stream of Ca21 release induced by NT3? CaMKII may
serve as an excellent candidate, because its role in trans-
mitter release is relatively well-defined (Llinas et al., 1985;
Lin et al., 1990; Nichols et al., 1990; Stanton and Gage,
1996; Jin et al., 1998; for review see Greengard et al.,
1993). Extensive studies indicate that the activation of
CaMKII is triggered by Ca21 influx through extracellular
sources. An important finding in this study is that CaMKII
can also be activated by Ca21 released from internal stores
through IP3 and ryanodine receptors. We showed that
even in the complete absence of Ca21 influx, the NT3-
induced potentiation of transmitter release can be blocked
by the CaMKII inhibitors CaMKII-pep or KN62. Further-
more, we found that KN62 can reverse established synap-
tic potentiation after NT3 application in Ca21-free me-
dium. These results not only provide a link between
internal Ca21 stores and CaMKII activation, but also point
to CaMKII as a downstream signaling mediator for NT3-
induced synaptic potentiation. Since it is difficult to test
whether the activation of CaMKII alone is sufficient to
mimic the NT3 effect, we can not rule out the possible in-
volvement of other processes that may also contribute to
the NT3-induced synaptic potentiation.
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